Reason for request
Inclusion
Clinical Benefit
| Insufficient |
The actual benefit of CLIMASTON 0.5 mg/2.5 mg is insufficient for reimbursement by National Health Insurance in the Marketing Authorisation indication. |
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
DsMBrVZBmEzrGr78
